Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04054310 · ClinicalTrials.gov registry record · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
A NA study of NASH - Nonalcoholic Steatohepatitis, sponsored by Perspectum.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 7
- Study locations
NCT04054310 is a NA study of NASH - Nonalcoholic Steatohepatitis that is actively recruiting participants, run by Perspectum. The registered enrollment target is 225 participants, below the 261-participant average among 27 other NASH - Nonalcoholic Steatohepatitis trials with a reported enrollment target (14% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT04054310, a NA study of NASH - Nonalcoholic Steatohepatitis, is actively recruiting participants, sponsored by Perspectum.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 7
- Study locations
Study Summary
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Liver Multi Scan
Study Locations (7)
Virginia
- University of Virginia - Charlottesville
- Virginia Common wealth University - Richmond
Arizona
- Arizona Liver Health - Chandler
Illinois
- RUSH University Medical Center - Chicago
Indiana
- Indiana University Health - Indianapolis
New York
- Icahn School of Medicine at Mount Sinai - New York
Texas
- Liver Center of Texas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2020-08-05 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04054310
The ClinicalTrials.gov registry entry for NCT04054310 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 27 other NASH - Nonalcoholic Steatohepatitis trials with a reported enrollment target (14% lower). The listed sponsor is Perspectum, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with NASH - Nonalcoholic Steatohepatitis appearing as the primary indexed condition, and to 1 intervention - of which Liver Multi Scan is the first listed.
NCT04054310 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Virginia, Arizona, Illinois.
Frequently Asked Questions
What is clinical trial NCT04054310 about?
NCT04054310 is a clinical study titled "Non-Invasive Quantification of Liver Health in NASH (N-QUAN)". To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
What is the current status of trial NCT04054310?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2020-08-05. Estimated completion is 2026-02-01.
What conditions does trial NCT04054310 study?
This clinical trial studies the following conditions: NASH - Nonalcoholic Steatohepatitis.
What interventions are being tested in trial NCT04054310?
The interventions under investigation include: Liver Multi Scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04054310?
This trial is sponsored by Perspectum, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04054310 being conducted?
This trial has 7 study locations across Arizona, Illinois, Indiana, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NASH - Nonalcoholic Steatohepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
RECRUITING · NA
-
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis
RECRUITING · NA
-
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis
ACTIVE NOT RECRUITING · NA
-
Hepatic Energy Fluxes in NASH and NAS Patients
ACTIVE NOT RECRUITING · NA
-
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
RECRUITING
-
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.